HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gary L Griffiths Selected Research

chloramine-T (Clorina)

3/2004Preclinical therapy of breast cancer with a radioiodinated humanized anti-EGP-1 monoclonal antibody: advantage of a residualizing iodine radiolabel.
1/2003Improved iodine radiolabels for monoclonal antibody therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gary L Griffiths Research Topics

Disease

17Neoplasms (Cancer)
01/2020 - 06/2002
3Glioma (Gliomas)
02/2013 - 12/2008
2Prostatic Neoplasms (Prostate Cancer)
11/2016 - 07/2015
2Hypersensitivity (Allergy)
07/2015 - 08/2014
2Breast Neoplasms (Breast Cancer)
11/2011 - 03/2004
2Brain Neoplasms (Brain Tumor)
06/2009 - 12/2008
2Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2005 - 01/2003
2Lymphoma (Lymphomas)
12/2003 - 01/2003
1Melanoma (Melanoma, Malignant)
05/2015
1Drug Hypersensitivity (Drug Allergy)
08/2014
1Adenomatous Polyps
08/2011
1Polyps
08/2011
1Inflammation (Inflammations)
11/2010
1Dyslipidemias (Dyslipidemia)
08/2010
1Fabry Disease (Fabry's Disease)
08/2009
1Glycogen Storage Disease Type II (Pompe's Disease)
07/2009
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2008
1Brain Diseases (Brain Disorder)
06/2008
1Stroke (Strokes)
06/2008
1Infections
10/2006
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2005
1Multiple Myeloma
07/2005
1Residual Neoplasm
04/2005
1Colonic Neoplasms (Colon Cancer)
04/2005
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2003
1Renal Cell Carcinoma (Grawitz Tumor)
09/2003
1Carcinoma (Carcinomatosis)
06/2002

Drug/Important Bio-Agent (IBA)

6Monoclonal AntibodiesIBA
01/2020 - 09/2003
6Pharmaceutical PreparationsIBA
01/2020 - 12/2003
5AntibodiesIBA
11/2014 - 06/2002
4Radioisotopes (Radionuclides)IBA
04/2005 - 01/2003
3AntigensIBA
01/2020 - 01/2003
3Immunoconjugates (Immunoconjugate)IBA
01/2020 - 07/2005
3EnzymesIBA
08/2009 - 10/2006
3Peptides (Polypeptides)IBA
09/2003 - 01/2003
2Ferrosoferric Oxide (Magnetite)FDA Link
11/2016 - 07/2015
2Contrast MediaIBA
11/2016 - 06/2008
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2011 - 01/2003
2LipidsIBA
11/2010 - 08/2010
2Fluorescent Dyes (Fluorescent Probes)IBA
08/2009 - 07/2009
2Proteins (Proteins, Gene)FDA Link
08/2009 - 01/2004
2Dendrimers (Dendrons)IBA
06/2009 - 12/2008
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2006 - 07/2005
2IodineIBA
04/2005 - 03/2004
2chloramine-T (Clorina)IBA
03/2004 - 01/2003
2Pentetic Acid (DTPA)FDA LinkGeneric
09/2003 - 01/2003
1Coloring Agents (Dyes)IBA
01/2020
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2014
1Cell Surface ReceptorsIBA
11/2014
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
08/2014
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
08/2014
1Tiopronin (Thiola)FDA Link
08/2014
1Small Interfering RNA (siRNA)IBA
02/2013
1Carmustine (FIVB)FDA Link
02/2013
1StathminIBA
02/2013
1Glycoproteins (Glycoprotein)IBA
08/2011
1LectinsIBA
08/2011
1CarbohydratesIBA
08/2011
1rhodamine BIBA
08/2011
1FucoseIBA
08/2011
1Iohexol (Omnipaque)FDA Link
08/2011
1AgglutininsIBA
08/2011
1Liposomes (Liposome)IBA
08/2011
1MucinsIBA
08/2011
1Biomarkers (Surrogate Marker)IBA
08/2011
1Ulex europaeus lectinsIBA
08/2011
1Lipoproteins (Lipoprotein)IBA
08/2010
1CholesterolIBA
08/2010
1CytokinesIBA
08/2010
1GlycosphingolipidsIBA
08/2009
1alpha-Galactosidase (Beano)IBA
08/2009
1globotriaosylceramide (globotriosylceramide)IBA
08/2009
1alpha-Glucosidases (Acid Maltase)IBA
07/2009
1GlycogenIBA
07/2009
1Phenobarbital (Luminal)FDA Link
06/2009
1Poly(amidoamine)IBA
12/2008
1AntioxidantsIBA
06/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2008
1ImmunosorbentsIBA
10/2006
1HLA-DR Antigens (HLA-DR)IBA
07/2005
1IMMU-110IBA
07/2005
1Humanized Monoclonal AntibodiesIBA
05/2005
1Immunotoxins (Immunotoxin)IBA
05/2005
1Indicators and Reagents (Reagents)IBA
01/2004
1AnthracyclinesIBA
12/2003
1Therapeutic UsesIBA
09/2003
1AcidsIBA
09/2003
1YttriumIBA
01/2003
1epratuzumabIBA
01/2003
1Chelating AgentsIBA
01/2003
1StreptavidinIBA
06/2002
1Carcinoembryonic AntigenIBA
06/2002

Therapy/Procedure

10Therapeutics
01/2020 - 01/2003
5Radioimmunotherapy
08/2005 - 01/2003
4Drug Therapy (Chemotherapy)
01/2020 - 08/2005
1Immunotherapy
05/2015
1Intravenous Infusions
06/2009